GL1X · GenesisL1 explorer

MolNFT v1 · #128303 · protein

868 TCR specific for HLA A02 presenting HIV epitope slyntvatl

5NMD · Human T-cell receptor alpha chain: “868 TCR specific for HLA A02 presenting HIV epitope slyntvatl”. X-ray diffraction, 1 ligand (SO4), 13 pockets (best druggability 0.79). MolNFT v1 #128303 on GenesisL1: 3D structure, binding sites…

PDB
5NMD
Type
protein
Length
884 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Human T-cell receptor alpha chain; Human T-cell receptor, beta chain
Ligands
SO4
Pockets
13 · best druggability 0.79

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 49% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, CHuman T-cell receptor alpha chainprotein2005% helix, 47% strand—
B, DHuman T-cell receptor, beta chainprotein2427% helix, 50% strand—

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 5 copies · chains A, B, C, D
  • EDO · 1,2-ethanediol · additive · 4 copies · chains A, B, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

13 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14780.790.8767EDO
26520.750.8174empty
32950.710.8544EDO
41150.530.8221empty
51100.400.7524empty

Interfaces

3 interfaces between chains.

  • A–B · 2161 Ų buried · 28 hydrogen bonds · protein-protein
  • C–D · 2099 Ų buried · 26 hydrogen bonds · protein-protein
  • A–C · 965 Ų buried · 16 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 10 disulfide (disulfide).

Compared structures

  • 5NMD · 868 TCR Specific for HLA A02 presenting HIV Epitope SLYNTVATL · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.